ERBB2 and breast carcinoma: Within the subtypes of breast cancer, one stands out as highly aggressive, coupled with a triple negative histotype for estrogen receptor α (ESR1), progesterone receptor (PR) and human epidermal growth factor 2 (HER2) [2].